Johnson & Johnson (NYSE: JNJ) is -12.80% lower on its value in year-to-date trading and has touched a low of $150.71 and a high of $186.69 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The JNJ stock was last observed hovering at around $154.35 in the last trading session, with the day’s loss setting it -0.32% off its average median price target of $180.00 for the next 12 months. It is also 28.36% off the consensus price target high of $215.00 offered by 19 analysts, but current levels are 4.33% higher than the price target low of $161.00 for the same period.
Currently trading at $154.03, the stock is -0.70% and -5.80% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.54 million and changing -0.21% at the moment leaves the stock -9.20% off its SMA200. JNJ registered -12.55% loss for a year compared to 6-month loss of -6.46%.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
The stock witnessed a -4.94% gain in the last 1 month and extending the period to 3 months gives it a -14.05%, and is 1.84% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.71% over the week and 1.43% over the month.
Johnson & Johnson (JNJ) has around 152700 employees, a market worth around $400.16B and $94.94B in sales. Current P/E ratio is 22.86 and Fwd P/E is 14.14. Profit margin for the company is 18.90%. Distance from 52-week low is 2.20% and -17.49% from its 52-week high. The company has generated returns on investments over the last 12 months (15.40%).
Johnson & Johnson (JNJ) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Johnson & Johnson (JNJ) is a “Overweight”. 19 analysts offering their recommendations for the stock have an average rating of 2.50, where 11 rate it as a Hold and 2 think it is a “Overweight”. 5 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Johnson & Johnson is expected to release its quarterly report on 04/18/2023.The EPS is expected to shrink by -13.70% this year
Johnson & Johnson (JNJ) Top Institutional Holders
The shares outstanding are 2.61B, and float is at 2.60B with Short Float at 0.45%.
Johnson & Johnson (JNJ) Insider Activity
A total of 355 insider transactions have happened at Johnson & Johnson (JNJ) in the last six months, with sales accounting for 315 and purchases happening 40 times. The most recent transaction is an insider sale by Swanson James D., the company’s. SEC filings show that Swanson James D. sold 1,062 shares of the company’s common stock on Mar 06 at a price of $154.66 per share for a total of $0.16 million. Following the sale, the insider now owns 9215.0 shares.
Johnson & Johnson disclosed in a document filed with the SEC on Dec 13 that Wolk Joseph J (Exec VP, CFO) sold a total of 14,781 shares of the company’s common stock. The trade occurred on Dec 13 and was made at $179.60 per share for $2.65 million. Following the transaction, the insider now directly holds 35812.0 shares of the JNJ stock.
Still, SEC filings show that on Nov 30, McEvoy Ashley (EVP, WW Chair, MedTech) disposed off 73,323 shares at an average price of $175.47 for $12.87 million. The insider now directly holds 41,813 shares of Johnson & Johnson (JNJ).
Johnson & Johnson (JNJ): Who are the competitors?
The company’s main competitors (and peers) include The Procter & Gamble Company (PG) that is trading -4.91% down over the past 12 months and Rogers Corporation (ROG) that is -44.12% lower over the same period.